HIMS News

SHAREHOLDER WARNING: Kahn Swick & Foti, LLC Urges Investors with $100,000+ in Losses to Act Now in Class Action Against Hims & Hers Health, Inc. – HIMS

Kaplan Fox Notifies Hims & Hers Health, Inc. (HIMS) Investors of a Pending Securities Class Action Deadline on November 2, 2026 Ready to Announce with Confidence?

DEADLINE ALERT for HYLN, HIMS, UNCY, BIDU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

HIMS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 Ready to Announce with Confidence?

INVESTOR ALERT: Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership